43 research outputs found
Unsupervised Syntactically Controlled Paraphrase Generation with Abstract Meaning Representations
Syntactically controlled paraphrase generation has become an emerging
research direction in recent years. Most existing approaches require annotated
paraphrase pairs for training and are thus costly to extend to new domains.
Unsupervised approaches, on the other hand, do not need paraphrase pairs but
suffer from relatively poor performance in terms of syntactic control and
quality of generated paraphrases. In this paper, we demonstrate that leveraging
Abstract Meaning Representations (AMR) can greatly improve the performance of
unsupervised syntactically controlled paraphrase generation. Our proposed
model, AMR-enhanced Paraphrase Generator (AMRPG), separately encodes the AMR
graph and the constituency parse of the input sentence into two disentangled
semantic and syntactic embeddings. A decoder is then learned to reconstruct the
input sentence from the semantic and syntactic embeddings. Our experiments show
that AMRPG generates more accurate syntactically controlled paraphrases, both
quantitatively and qualitatively, compared to the existing unsupervised
approaches. We also demonstrate that the paraphrases generated by AMRPG can be
used for data augmentation to improve the robustness of NLP models.Comment: Paper accepted by EMNLP 2022 Findings. The first two authors
contribute equall
A review on computer vision based defect detection and condition assessment of concrete and asphalt civil infrastructure
To ensure the safety and the serviceability of civil infrastructure it is essential to visually inspect and assess its physical and functional condition. This review paper presents the current state of practice of assessing the visual condition of vertical and horizontal civil infrastructure; in particular of reinforced concrete bridges, precast concrete tunnels, underground concrete pipes, and asphalt pavements. Since the rate of creation and deployment of computer vision methods for civil engineering applications has been exponentially increasing, the main part of the paper presents a comprehensive synthesis of the state of the art in computer vision based defect detection and condition assessment related to concrete and asphalt civil infrastructure. Finally, the current achievements and limitations of existing methods as well as open research challenges are outlined to assist both the civil engineering and the computer science research community in setting an agenda for future research
LegalBench: A Collaboratively Built Benchmark for Measuring Legal Reasoning in Large Language Models
The advent of large language models (LLMs) and their adoption by the legal community has given rise to the question: what types of legal reasoning can LLMs perform? To enable greater study of this question, we present LegalBench: a collaboratively constructed legal reasoning benchmark consisting of 162 tasks covering six different types of legal reasoning. LegalBench was built through an interdisciplinary process, in which we collected tasks designed and hand-crafted by legal professionals. Because these subject matter experts took a leading role in construction, tasks either measure legal reasoning capabilities that are practically useful, or measure reasoning skills that lawyers find interesting. To enable cross-disciplinary conversations about LLMs in the law, we additionally show how popular legal frameworks for describing legal reasoning—which distinguish between its many forms—correspond to LegalBench tasks, thus giving lawyers and LLM developers a common vocabulary. This paper describes LegalBench, presents an empirical evaluation of 20 open-source and commercial LLMs, and illustrates the types of research explorations LegalBench enables
LegalBench: A Collaboratively Built Benchmark for Measuring Legal Reasoning in Large Language Models
The advent of large language models (LLMs) and their adoption by the legal
community has given rise to the question: what types of legal reasoning can
LLMs perform? To enable greater study of this question, we present LegalBench:
a collaboratively constructed legal reasoning benchmark consisting of 162 tasks
covering six different types of legal reasoning. LegalBench was built through
an interdisciplinary process, in which we collected tasks designed and
hand-crafted by legal professionals. Because these subject matter experts took
a leading role in construction, tasks either measure legal reasoning
capabilities that are practically useful, or measure reasoning skills that
lawyers find interesting. To enable cross-disciplinary conversations about LLMs
in the law, we additionally show how popular legal frameworks for describing
legal reasoning -- which distinguish between its many forms -- correspond to
LegalBench tasks, thus giving lawyers and LLM developers a common vocabulary.
This paper describes LegalBench, presents an empirical evaluation of 20
open-source and commercial LLMs, and illustrates the types of research
explorations LegalBench enables.Comment: 143 pages, 79 tables, 4 figure
Robust estimation of bacterial cell count from optical density
Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
The Efficiency of the Large Synoptic Survey Telescope for Finding Planet Nine-Like Objects
The alignments of distant Kuiper Belt objects suggest the presence of another gravitational object in the Solar System, currently denoted as Planet Nine. The object has not been observed by current sky surveys, however given its predicted orbit, its location is likely to be in the observational limits of the future Large Synoptic Survey Telescope (LSST). The telescope will conduct a ten-year survey of the sky that will produce a comprehensive catalogue of objects 10-100 times greater than the current record, improving models of Solar System formation and evolution. This investigation compares current mapping strategies of LSST in their ability to observe Planet Nine- like objects, given its expected orbit. A metric was designed to calculate the probability Planet Nine is in the observational limits of the survey, using LSST Stack software and Anaconda Python framework. Running simulated sky surveys with mapping strategies of LSST through this metric provide a strategy’s chance of observing Planet Nine. Preliminary results suggest that strategies extending north have a greater probability in observing Planet Nine. The metric created for this investigation can be applied to find other objects like Planet Nine during the lifespan of the LSST, improving the catalogue of the solar system
Effect of counseling on newly diagnosed Type 2 diabetes mellitus patients visiting a tertiary care hospital: A randomized control trial
A remarkable case of rhabdomyolysis associated with ingestion of energy drink ‘neon volt’
Rhabdomyolysis is defined as a syndrome characterized by muscle necrosis and the release of intracellular muscle constituents into the circulation. We present a case of a 35-year-old male who exercised for 2 h after ingesting energy drink and subsequently presented with rhabdomyolysis. After excluding common and uncommon causes of rhabdomyolysis, we reached the conclusion that the likely cause was the ingestion of energy drink ‘NEON VOLT’ in a setting of mild dehydration. Increasing physical activity and intense exercise is becoming a trend in many countries, due to its many health-related benefits such as prevention of obesity. This renewed focus toward optimal fitness has spawned many supplements that aid in improvement of the performance, muscle growth, and recovery. Energy drinks predominantly contain caffeine that is often combined with other supplements to form what manufacturers have termed an ‘energy blend’. Studies have shown that excessive caffeine intake from energy drinks can cause arrhythmias, hypertension, dehydration, sleeplessness, nervousness, and in rare instances, rhabdomyolysis. As per Drug Abuse Warning Network report, there is a sharp increase in the number of emergency department visits involving energy drinks from 1,128 visits in 2005 to 16,053 and 13,114 visits in 2008 and 2009, respectively. Due to emergence of energy drink abuse as a national health problem, Food and Drug Administration has launched a dietary supplement adverse event reporting system for surveillance of any adverse events linked to these agents